rxstat › Classes › Hypothalamic Hormones

Hypothalamic Hormones: shortage status in Canada

2 of the 4 hypothalamic hormones rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Gonadorelin (Lutrepulse) Partial shortage 1 of 2 reported products affected Octreotide (Sandostatin Lar) Partial shortage 3 of 14 reported products affected · est. return Nov 30, 2026 Lanreotide (Mytolac) No current shortage Pasireotide (Signifor) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.